KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

Stock Information for Apyx Medical Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Apyx Medical Corporation

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
KORU Medical Systems to Participate in Upcoming Investor Conferences
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
Cirtec Medical Announces Appointment of New Chief Executive Officer
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.